Nigeria has received 11,520 doses of lenacapavir, a long-acting injectable HIV prevention medicine, as part of a Global Fund-supported initiative.
The federal government officially took delivery of the consignment on Wednesday at the Federal Central Stores, Oshodi, Lagos.
The target population for this prevention commodity includes serodiscordant couples, people at risk of HIV/AIDS, and key populations such as men who have sex with men, female sex workers, and transgender persons.
The injection will be provided free of charge to enrolled clients at designated health facilities in eight pilot states: Kwara, Gombe, Ebonyi, Anambra, FCT, Akwa Ibom, Cross River, and Benue.
Oladipupo Fisher, Lagos state AIDS programme coordinator, said the introduction of lenacapavir strengthens the country’s multi-pronged prevention strategy, aiming to eliminate HIV/AIDS by 2030.
The injection is expected to reduce new infections and contribute to epidemic control.
